SEC Filing Summary: DNA X, Inc. (SONM)
Business Context and Reporting Period
This Form 8-K was filed by DNA X, Inc. on May 20, 2026. The filing serves to announce the Company's financial results for the fiscal quarter ended March 31, 2026, pursuant to Item 2.02. The Company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol SONM.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a notification that a press release containing these details has been issued and is attached as Exhibit 99.1.
Material Changes
The filing does not contain data to compare current period performance against prior periods. Investors must refer to the attached press release (Exhibit 99.1) for details on material changes in financial condition or results of operations.
Guidance, Outlook, and Risks
The provided text contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. The filing strictly references the issuance of the press release regarding the Q1 2026 results.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for the quarter ended March 31, 2026.
- Verify year-over-year and quarter-over-quarter growth rates in the attached press release.
- Check for any updated financial guidance or strategic initiatives mentioned in the press release.
- Confirm the Company's liquidity position and debt obligations as detailed in the full financial statements referenced in the press release.